Standigm Raises US $11.5 Million in Series B Round Funding to advance its AI-powered drug pipelines toward license-out. – Bio-IT World

Standigm Raises US $11.5 Million in Series B Round Funding to advance its AI-powered drug pipelines toward license-out. – Bio-IT World
Standigm Raises US $11.5 Million in Series B Round Funding to advance its AI-powered drug pipelines toward license-out.  Bio-IT WorldSEOUL, SOUTH KOREA - Mar 29, 2019 - Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it ... read more
Source: Google NewsPublished on 2019-03-26